Neuroendocrine Cancer

Understanding how I fit in matters to me but figuring out my identity in the cancer space is not always easy.

My diagnosis of neuroendocrine carcinoma gave me a new perspective on life.

I was diagnosed with kidney cancer and pancreatic neuroendocrine tumors two years ago, but I’ve learned a lifetime of lessons since.

During my time with cancer, I've come across words associated with cancer that I don't like and some that I appreciate.

Lutathera was approved for patients 12 or older with SSTR-positive gastroenteropancreatic neuroendocrine tumors, the FDA announced.

Anxiety over scans makes sense, but isn’t there more anxiety about other cancer tests, too?

When life hands you cancer lemons, what flavored lemonade do you make?

The waiting in between scans heightens my scanxiety, even though I've had no evidence of disease for 2 1/2 years.

Lutathera plus Sandostatin improved progression-free survival in patients with advanced gastric neuroendocrine tumors, research showed.

Patients with neuroendocrine tumors or neuroblastoma could be treated with a different approach based on a protein that may be a potential biomarker.

After cancer, taking baby steps towards stuff you want to do is what matters.

After being diagnosed with a neuroendocrine cancer, I underwent seven phases of resiliency.

We all know that stress is bad.

I have cancer and don't believe in god, can I still be spiritual?

Treatment combination of Lutathera and Sandostatin improved outcomes for patients with gastroenteropancreatic neuroendocrine tumors.

Patients "need to be proactive" as they coordinate care between two diseases.

From Jill Martin revealing an updated about her cancer to Casey DeSantis announcing breast cancer diagnosis, this is what’s happening in the oncology space this week.

From Stand Up to Cancer honoring survivors at a Minor League baseball game, to Maria Menounos showing her cancer scars on Instagram, here’s what’s happening in the oncology space this week.

I was diagnosed with cancer just as the pandemic hit.

Sure, knowledge is power, but there’s comfort in naïveté, too, when it comes to expectations for cancer care.

A cancer diagnosis often means putting your life in the hands of people you hardly know.

The day I got diagnosed with cancer, I went from “person” to “patient” — and the title has followed me ever since.

In part of the “Star Wars” saga, a character mentions that rebellions are built on hope. After being diagnosed with cancer, I’ve realized that the same is true for patients with the disease.

Experts are concerned that the train derailment in Ohio may pose cancer risks down the line.

A new standard of care for advanced pancreatic neuroendocrine tumors demonstrates improvements in survival and tumor shrinkage.

Researchers just launched a phase 2 trial evaluating iadademstat plus paclitaxel in patients with relapsed/refractory neuroendocrine cancer, including those with small cell lung cancer.

Maintaining independence was found to the be the most common health care goal in patients with stage 4 neuroendocrine tumors, a recent survey found.

A phase 2 clinical trial will evaluate iadademstat for patients with relapsed or refractory high-grade neuroendocrine carcinoma.

A novel drug, MRT-2359, will be studied in a phase 1/2 trial for patients with MYC-driven cancers.

The Food and Drug Administration will fast track the development and review of ITM-11 for the treatment of gastroenteropancreatic neuroendocrine tumors.